In Vivo Gastric Expression of FTO and MC4R in Sleeve Gastrectomy Patients: Diagnostic Utility Without Predictive Value for Weight Loss - Summary - MDSpire

In Vivo Gastric Expression of FTO and MC4R in Sleeve Gastrectomy Patients: Diagnostic Utility Without Predictive Value for Weight Loss

  • By

  • Mohamed Hany

  • Mona K. ElDeeb

  • Ehab Elmongui

  • Anwar Ashraf Abouelnasr

  • Noha A. El-Banna

  • Sahar M. omer

  • Sara A. Shaker

  • Rasha A. ElTahan

  • December 9, 2025

  • 0 min

Share

Objective:

To investigate the gastric expression of FTO and MC4R genes in sleeve gastrectomy patients and assess their diagnostic utility and predictive value for weight loss, highlighting the significance of these findings in obesity treatment.

Key Findings:
  • FTO and MC4R genes are expressed in gastric tissues, potentially influencing local gastric functions, including increased gastric acid secretion.
  • Increased gastric acid secretion was observed in obese mouse models, linked to gastrin signaling.
  • No direct correlation was found between gastric gene expression and overall body fat or systemic metabolic status.
Interpretation:

While FTO and MC4R expression in the gastric wall may reflect local metabolic changes, they do not predict weight loss outcomes in sleeve gastrectomy patients, suggesting a need for further research into their roles.

Limitations:
  • Lack of direct correlation between gastric gene expression and systemic metabolic outcomes.
  • Inconsistencies in findings related to genetic variants and weight loss across existing literature, including potential biases.
Conclusion:

The study highlights the potential role of gastric gene expression in metabolic regulation but suggests that FTO and MC4R may not serve as reliable predictors for weight loss post-surgery, emphasizing the need for further exploration in obesity management.

Original Source(s)

Related Content